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Summary. Lymphatic ﬁlariasis is one of several neglected tropical diseases
with severely disabling and stigmatizing manifestations that are referred to as
‘neglected diseases of poverty’. It is a mosquito-borne disease found endemi-
cally and exclusively in low-income contexts where, concomitantly, general
public health care is often deeply troubled and fails to meet the basic health
needs of impoverished populations. This presents particular challenges for the
implementation of mass drug administration (MDA), which currently is the
principal means of control and eventual elimination. Several MDA programmes
face the dilemma that they are unable to attain and maintain the required drug
coverage across target groups. In recognition of this, a qualitative study was
conducted in the Morogoro and Lindi regions of Tanzania to gain an under-
standing of community experiences with, and perceptions of, the MDA cam-
paign implemented in 2011 by the National Lymphatic Filariasis Elimination
Programme. The study revealed a wide variation of perceptions and experiences
regarding the aim, rationale and justiﬁcation of MDA. There were positive
sentiments about the usefulness of the drugs, but many study participants were
sceptical about the manner in which MDA is implemented. People were partic-
ularly disappointed with the limited attempts by implementers to share infor-
mation and mobilize residents. In addition, negative sentiments towards MDA
for lymphatic ﬁlariasis reﬂected a general feeling of desertion and marginaliza-
tion by the health care system and political authorities. However, the results
suggest that if the communities are brought on board with genuine respect for
their integrity and informed self-determination, there is scope for major improve-
ments in community support for MDA-based control activities.
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Introduction
Lymphatic ﬁlariasis, a devastating disease caused by ﬁlarial nematode worms and
spread by mosquitoes, is found in more than 80 countries (WHO, 2010; Simonsen et al.,
2014). The infection damages the human lymphatic system and its acute and chronic
complications cause considerable disability in affected individuals. An estimated 40 million
people are incapacitated or disﬁgured with swollen genitalia (hydrocoele) or dramatically
thickened limbs, with hard, rough and ﬁssured skin (lymphoedema/elephantiasis) (WHO,
2013). Affected individuals suffer social and economic consequences due to stigma and
reduced productive capacity resulting from these complications (WHO, 2013).
The World Health Organization, through its Global Programme to Eliminate
Lymphatic Filariasis (GPELF), has targeted the disease for elimination as a public
health problem by 2020 through a dual strategy of mass drug administration (MDA)
to interrupt transmission of infection and morbidity control to alleviate disability of
people affected by the acute and chronic manifestations (Gyapong et al., 2005; Ottesen,
2006; Kyelem et al., 2008; WHO, 2010, 2013). The MDA involves administering drugs
to entire endemic populations regardless of individuals’ infection status through the use
of a two-drug combination of either diethylcarbamazine or ivermectin combined with
albendazole once every year. A high treatment coverage of 65% in the endemic popu-
lation sustained for 5–6 years is required to effectively clear infected individuals and
stop the transmission (Michael et al., 2004; WHO, 2011). When a large proportion of
the population is not included, or refuses participation, in MDA, a potential reservoir
for the parasite is left untreated, thus opening the door to recrudescence of transmission
(Talbot et al., 2008; Boyd et al., 2010). A major challenge facing many MDA programmes
for lymphatic ﬁlariasis control has been to attain and sustain the high treatment coverage
required to interrupt transmission in endemic communities (e.g. Gunawardena et al., 2007;
Amarillo et al., 2008; Babu & Mishra, 2008; Njomo et al., 2012; Offei & Anto, 2014).
A complex set of individual, societal and health system factors has been given as an
explanation for the failure of the intervention to reach the optimal drug coverage
required to interrupt lymphatic ﬁlariasis transmission (Krentel et al., 2013). It is impor-
tant to identify and understand these factors in order to strengthen the programme
approach and increase treatment coverage.
Lymphatic ﬁlariasis is widespread in Tanzania, and coastal areas are characterized
by high levels of infection and disease (e.g. McMahon et al., 1981; Minjas & Kihamia,
1991; Meyrowitsch et al., 1995; Simonsen et al., 1995, 2002; Rwegoshora et al., 2005).
It is estimated that over 34 million individuals live in endemic foci in Tanzania and
that 5–6 million are affected by one or more clinical manifestations of lymphatic
ﬁlariasis (Malecela et al., 2009).
In Tanzania, lymphatic ﬁlariasis control is co-ordinated under the integrated
Neglected Tropical Disease (NTD) Control Programme, which also oversees MDAs for
other diseases under the NTD classiﬁcation including onchocerciasis, trachoma, schisto-
somiasis and soil-transmitted helminthiases. Mass drug administration for lymphatic
ﬁlariasis is based on annual application of a combination of ivermectin (150–200 mg/
kg body weight) and albendazole (400 mg/person) to individuals in endemic areas aged
b5 years. With the aim of improving the delivery of this intervention, the distribution
of drugs is carried out following the Community-Directed Intervention (CDI) strategy,
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which aims to have communities themselves direct the intervention, following initial
introduction to the intervention by local health workers and intervention partners.
According to the CDI strategy, individuals are selected among, and preferably by,
the community members to distribute drugs in their ‘communities’, meaning in the
geographical vicinity of their homes, usually for a minor fee (Mutalemwa et al., 2009;
Kisinza et al., 2008; CDI Study Group, 2010). Distributors are referred to as Com-
munity Drug Distributors (CDDs). In both rural and urban areas, CDDs visit other
inhabitants’ houses to distribute drugs to household members if they are at home. How-
ever, in some urban settings, drugs are also distributed in public places like institutions
and market places. According to CDI requirements, staff from local health facilities are
responsible for training the drug distributors, supplying drugs brought to them from the
district ofﬁces, supervising drug distribution, collecting data and reporting to the dis-
tricts. The implementation of MDA in Tanzania has been met with mixed reactions
ranging from appreciation, to passive acceptance to outright refusal in various com-
munities (Parker & Allen, 2013). Like in many other places, the drug uptake (com-
pliance) rates have often been sub-optimal (Simonsen et al., 2010, 2013; Kisoka et al.,
2014), but only a few studies have given attention to local perceptions of lymphatic
ﬁlariasis and MDA (Allen & Parker, 2011; Parker & Allen, 2013).
This paper presents data from the qualitative component of a Tanzanian mixed-
methods research project. That same project’s quantitative component included a
questionnaire-based cross-sectional household survey carried out in two rural and two
urban sites in Tanzania, shortly after the 2011 MDA campaign for lymphatic ﬁlariasis
(Kisoka et al., 2014). In this survey, 3279 adults were interviewed about MDA drug
uptake among themselves and their children and asked their reasons for taking or not
taking drugs. The study reported an overall drug uptake rate of 55.1% (range of 44.5–
75.6% between sites) and that the main reasons for not taking the drugs were that
people were either not at home at the time of distribution, or that they had not been
offered the drugs.
The qualitative research data reported in this paper are based on interviews and
focus group discussions with community members from the same four sites in Tanzania
shortly after they had been targeted for MDA for lymphatic ﬁlariasis. The primary focus
was to gain insight into targeted community members’ perceptions and experiences of
lymphatic ﬁlariasis, the drugs distributed and the phenomenon of MDA so as to indicate
ways of improving the intervention and the interaction between populations and the inter-
vention for future campaigns. This insight may also be relevant to MDA campaigns for
other neglected tropical diseases.
The research sites
The study was conducted in the Morogoro and Lindi regions of Tanzania (Fig. 1).
According to the 2012 National Census, Lindi region had a population of 864,652, of
which 78,841 lived in the regional capital of Lindi town, while Morogoro region had a
population of 2,218,492, of which 315,866 lived in the regional capital of Morogoro
town (NBS, 2013). From each region, one rural and one urban study site located at a
considerable distance from each other were selected. In Lindi region, the rural site (in
the following called Lindi Rural) was located in Lindi rural district about 75 km from
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the urban site in Lindi town (in the following called Lindi Urban), while in Morogoro
region the rural site (in the following called Morogoro Rural) was located in Morogoro
rural district about 150 km from the urban site in Morogoro town (in the following
called Morogoro Urban).
The populations in the two rural study sites mainly comprise Makonde in Lindi
Rural and Luguru and Kutu in Morogoro Rural, while in the two urban study sites
the populations are rather mixed and also include people of Indian and Arab origin.
However, while the population in Lindi Rural can be described as relatively homoge-
neous and stable, that of Morogoro Rural includes Maasai and Sukuma who have
moved and settled in the areas in search of grazing land for their livestock. The settle-
ment of these groups has been characterized by conﬂicts with the indigenous popula-
tion over land use and occupancy. The great majority of the inhabitants of Lindi Region
are Muslim, whereas in Morogoro region there is an approximate equal proportion of
Muslims and Christians. There are no obvious religious tensions in the study sites.
In the rural areas, the majority of the residential premises are located along the
main roads while the farms are located further inland. Houses are characteristically
Fig. 1. Map showing the location of the study sites in Lindi and Morogoro regions,
Tanzania. Black: the two urban districts. Chequered: the two rural study districts.
Hatched: the remaining part of the two study regions. DSM: Dar es Salaam.
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built of mud and poles and roofed with grass or thatch although there are a few built of
bricks with corrugated iron roofs. People in the rural areas are involved in subsistence
farming of food and cash crops. In Lindi Rural the main food crops are maize and
cassava while cash crops include groundnuts and cashew nuts. There is also small-scale
ﬁshing. In Morogoro Rural the main food crops include maize, banana, rice, sorghum
and beans while cash crops include onions and sugar cane. There is also livestock keep-
ing of cattle, goats and chickens. In both Lindi and Morogoro Urban people are
mainly employed in formal and informal sectors, including civil service, private sector
employment and business. There is industrial sector production in Morogoro Urban
while in Lindi Urban people are also engaged in small-scale ﬁshing.
Administratively, the districts in Tanzania are divided into wards. Six of thirteen
wards in Lindi Urban were selected for the study (four central and two peri-urban:
Rahaleo, Matopeni, Nachingwea, Mwenge, Mtanda and Msinjahili) while three of
nineteen wards in Morogoro Urban were selected for the study (one central and two
less central: Kingo, Kichangani and Kingolwira). The four central wards selected
from Lindi Urban were located close to the headquarters of the municipal council and
regional headquarters. The regional referral hospital for Lindi and three dispensaries
were easily accessible for residents of these wards. Each of the two peri-urban wards
from Lindi Urban also had a dispensary. One of the wards selected from Morogoro
urban was centrally located compared with the other two, although none of them could
be classiﬁed as peri-urban. Residents in these wards were all within easy reach of health
services. One ward was selected for the study in each of Lindi Rural (Nachunyu) and
Morogoro Rural (Mngazi). There was a health centre in Nachunyu and a dispensary in
Mngazi ward.
Methods
The study was qualitative and comprised of interviews and focus group discussions
(FGDs) held at the four study sites. These activities were carried out within one week
after MDA for lymphatic ﬁlariasis had been completed at the study sites (i.e. in Lindi
in May 2011 and in Morogoro in August 2011).
The interviewees comprised 21 CDDs, evenly distributed according to sex. The age
range of CDD participants was 20–53 years, and most were in their 40s. Four male
and ﬁve female CDDs were from Morogoro Rural, and two male and four female
CDDs were from Morogoro Urban. In Lindi Rural only one male CDD was interviewed,
while in Lindi Urban three male and two female CDDs were interviewed. Half of the
interviewed CDDs reported that they participated in the MDA for the ﬁrst time, while
the others had participated one or more times previously. Eleven community leaders, all
males, were interviewed. Of these, four were from Morogoro Rural, two from Morogoro
Urban, three from Lindi Rural and two from Lindi Urban. Six religious leaders, all
males, were also interviewed. Three were from Morogoro Rural, one from Morogoro
Urban and two from Lindi Rural, while there was none from Lindi Urban. Health
workers manning health facilities serving communities in study areas provided informa-
tion that mutually contrasted, complemented and contextualized community perception
on health problems and health services.
Eighteen FGDs with community members representing groups of adults and ado-
lescents of both sexes were organized. There were ﬁve group sessions with young males
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(two in each district except Morogoro Rural where only one session was organized),
ﬁve with young females (one in each district except Lindi Urban where two sessions
were held) and four sessions for adult males and four sessions for adult females, one
in each district. Each group comprised 8–12 discussants who were invited by com-
munity leaders one or two days prior to the discussions. The interviews and discussions
took place in convenient places where there was no interference from passers-by. The
interviewing and FGD process took cognizance of the fundamentals of collecting qual-
itative data, including promoting relaxed and trusting relationship with informants
and FGD participants, encouraging participation, observing non-verbal cues, probing,
noting silences, taking notes and opening and closing the interviews.
Interviews and FDGs were conducted in Swahili. Data collection tools were ﬁeld-
tested in a separate community before they were applied to the ﬁeld. They solicited in-
formation from the research participants regarding the most pressing health problems
faced by community members within their areas, health services available within their
residence and their experience with health services. The inquiry into their perception of
MDA for lymphatic ﬁlariasis sought information on the importance they attached to
lymphatic ﬁlariasis and about their awareness and perception of lymphatic ﬁlariasis
and the MDA process.
Data analysis
All ﬁeld notes including recorded interviews and conversations from FDGs were
transcribed verbatim and translated by trained social scientists. It is recognized that
transcription is not merely aimed at capturing the words of the participants, but also
meanings and perceptions that lend contexts and explanations to responses and be-
haviours (Kvale, 1996). Transcribers were trained to avoid summarizing statements
but instead to loyally represent slang, jargons, murmurs and sighs.
Transcribed data were carefully read and re-read by the research team in order to
gain a full overview of the ﬁeld data. Using thematic content analysis the research team
performed multiple-level data coding (Graneheim & Lundman, 2004). This was done
in an attempt to create codes that as closely as possible reﬂected the content of the
data rather than researchers’ pre-conceptions. Concepts used by the informants rather
than the questions raised in the interview guide were employed as codes. The coding
categories extracted from the transcripts and ﬁeld notes were used to systematically
analyse topics that were repeatedly mentioned in making up patterns of informants’
opinions and experiences. Concurrently, attention was paid to contradicting views and
experiences to reﬂect variations emerging in the data.
Ethics
Research and ethical clearance for the study was provided by the Medical Research
Coordinating Committee (MRCC) of the National Institute for Medical Research,
Tanzania (reference number NIMR/HQ/R.8a/Vol. IX/1073). Study purpose and pro-
cedures were explained to study participants before they gave informed verbal consent
to participate.
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Results
In this section the perceptions and concerns of the study population are presented under
the following four headings; perceptions of major health problems among community
members; concerns over the state of health care services; perception of lymphatic ﬁlar-
iasis; and, ﬁnally, perceptions concerning MDA.
Perceptions of major health problems among community members
With the purpose of contextualizing MDA for lymphatic ﬁlariasis within the general
experience of health and health care among community members, FGDs included a focus
on participants’ perception of the most common serious health problems they experience
in the community (Table 1). Among health workers, the question was asked in order to
ﬁnd out if there was common ground with community members with regard to health
problems and experience with provision of health services.
Table 1. An overview of the major health problems mentioned by community members during
focus group discussions in rural and urban study sites, Tanzania, listed according to priority with
those considered more severe ﬁrst
Area of residence
Informants Lindi Rural Morogoro Rural Lindi Urban Morogoro Urban
Boys STDsa
Cholera
Malaria
Malaria
Cholera
Skin diseases
Lymphatic ﬁlariasis
Eye diseases
Malaria
Diabetes
Stomach ulcers
Cholera
Lymphatic ﬁlariasis
Eye diseases
Malaria
Typhoid
Worms
Malnutrition
Girls Malaria
Diarrhoea
Coughing
Polio
Cholera
Skin diseases
Malaria
Lymphatic ﬁlariasis
Stomach problems
Diabetes
Cholera
Polio
Malaria
Schistosomiasis
Typhoid
Lymphatic ﬁlariasis
Men Malaria
Cough
Pneumonia
Injuries
Cholera
Eye problems
Fever
Skin diseases
Malaria
Worms
Cough
Malaria,
Cholera
Stomach problems
Lymphatic ﬁlariasis
Worms
Malaria
Typhoid
Diarrhoea
Cough
Women Malaria
Diarrhoea & vomiting
Eye diseases
Stomach ulcers
Respiratory infections
Fever
Malaria
Malaria
Diarrhoea
Diabetes
Cancer
Hypertension
Cough
Malaria
Diarrhoea
Lymphatic ﬁlariasis
aSexual transmitted diseases.
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Community members were most concerned about diseases related directly to mortality
as compared with those associated with morbidity. It is not surprising, therefore, that
malaria was mentioned in all but one focus group discussion. A group member said:
Malaria is the major disease that disturbs us especially during the rainy season. Although
we were given insecticide treated nets, malaria is still a big problem because the nets are
for use in our beds but what about when we are outdoors especially during evenings how
can we avoid the mosquitoes? (Adult male, Lindi Urban)
A discussant in another group echoed this statement when she said:
Malaria is a big problem because our environment is characterized by mosquitoes.
(Adult female, Morogoro Urban)
Environmental health concerns, including water-borne diseases such as diarrhoea, typhoid
and cholera, were mentioned in all groups from Lindi Region and a few from Morogoro
region.
As far as health problems are concerned in our area, I am not very far from my fellows;
another problem is lack of clean and safe water, therefore we are exposed to outbreaks.
(Adult male, Lindi Urban)
Eye problems and skin diseases were only mentioned by groups from Morogoro, while
STDs were only mentioned by a group of young men in Lindi Rural.
Lymphatic ﬁlariasis was mentioned in ﬁve groups, four of which were in urban
settings. In one of these groups discussants acknowledged it to be a big problem:
Lymphatic ﬁlariasis is a major problem here because people who have swollen legs and
hydrocoele exist in this area. (Adult women, Morogoro Urban)
In all groups where lymphatic ﬁlariasis was mentioned, hydrocoele was seen as a more
prevalent complication than elephantiasis. Most interviewed community leaders were
of the opinion that lymphatic ﬁlariasis was not a big problem within their areas, although
they acknowledged hydrocoele had occurred:
Lymphatic ﬁlariasis is not a big problem in my area. There is nobody with elephantiasis.
There was only one person who passed away several years ago. But those with hydrocoele
exist. It is just a common thing. (Muslim religious leader, Morogoro Rural).
Health workers conﬁrmed the health concerns of community members regarding infec-
tious diseases and shortages of essential medicine as threats to their health, and also
mentioned poor environmental health and sanitation. One health worker said:
There is a big problem of water shortage and thus outbreaks of diarrhoea, so they would
need an intervention on that. (Lindi Urban)
Health workers also mentioned health system constraints that concerned community
members:
The main complaint from people here is lack of laboratory services for diagnosing diseases.
People do not want to be given malaria drugs if they are not properly diagnosed using
laboratory equipment. (Lindi Rural)
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Health workers did not mention lymphatic ﬁlariasis among health problems they attend
to in their daily activities, although through participating in the MDA interventions
they acknowledged its presence.
Concerns about the state of health care services
In both urban and rural settings the health service was perceived to be extremely
poor and in every FGD participants lamented the poor state of local health services
available to their communities. This situation is made worse when community members
are forced to pay for poor quality services. In Morogoro Rural a young woman said:
If you go to the health facility, they ask you if you have health insurance. You say ‘yes I
have’, but they will tell you, there are no medicines. They give you a prescription and tell
you to go and buy medicines, while you have a health insurance. When is the government
going to bring medicines to our health facility?
Another participant chipped in:
It is true as the previous participants have just said. We don’t know how you will help us;
we are facing a big problem that sometimes people are left to die.
An adult woman from a rural community remarked:
We are not satisﬁed because for women who attend that facility during delivery, it is a
problem. Diagnostic equipment is not available, so we get treatment by guessing. (Morogoro
Rural)
Such despair was echoed in Lindi region where two FGDs with men emphasized their
experience of poor political support for advocacy for better health care. One adult man
in Lindi described it this way:
There is nothing we can do. Even when we raise our concerns with the higher authorities,
the only thing we get from them are promises to visit us. Our village executive ofﬁcer is
only allowed to visit ward ofﬁces, he is not allowed to go any further. It is the councillor
who has to take up the matter at the district but the councillor does not care about our
problems, he only goes for his own things. How come the councillor does not visit his
people for more than four months?
When asked about what therapy is available for lymphatic ﬁlariasis, community members
mentioned traditional medicine as well as biomedical hospital-based surgery for those
affected by hydrocoele. In one focus group in Morogoro, a young female participant
mentioned that some people with elephantiasis visited traditional healers. In another
group a discussant remarked:
There are a few cases of elephantiasis but many people have hydrocele. I am one of them.
I have been getting treatment at Mtwara. (Adult male, Lindi Rural)
In a group of women this was also raised when a participant remarked:
Yes, there are traditional medicines – people say they dig up the roots. If the swelling is
at early stages it disappears.
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Perceptions of lymphatic ﬁlariasis
There is no single Swahili word for lymphatic ﬁlariasis infection. The condition is
generally referred to by its common chronic disease complications of elephantiasis
and hydrocoele. The ofﬁcial Swahili translations for the two complications are matende
and mabusha. Hydrocoele is sometimes also referred to as ngiri maji or mshipa; the latter
word may also refer to hernia (sometimes people tend to refer to hydrocoele as mshipa
wa kushuka to distinguish it from hernia). In none of the FDGs was lymphatic ﬁlariasis
mentioned as a major health problem despite the MDA programme. Informants
acknowledged the presence of people who had either elephantiasis or hydrocoele within
their localities when they were asked. Informants in all discussions and interviews shared
the view that hydrocoele was a more important problem than elephantiasis because
more people had the former complication. In some places people thought elephantiasis
was non-existent in their communities:
There are no people with elephantiasis here, but a few with hydrocele. (Adult woman,
Lindi Rural)
One community leader shared this view:
Lymphatic ﬁlariasis is not a major problem in my area. There is nobody with elephantiasis.
But those with hydrocoele exist. (Religious leader, Morogoro Rural)
A community drug distributor voiced the same opinion when he said:
The problem of elephantiasis is not there, because no one is suffering from it but there
are a few who are suffering from hydrocoele, because our environment is attractive to
hydrocele. (Morogoro Rural)
Elephantiasis and hydrocele were assigned various causes by informants. The MDA
campaigns aim to inform community members that the tablets distributed by the
programme are meant to treat the infection that causes both these manifestations. The
diversity in the perceptions of the cause of lymphatic ﬁlariasis manifestations by com-
munity members is a reﬂection of the dysfunction in the communication strategy. This
point was provided by one of the distributors, who said:
From what I learned in school it is transmitted by mosquitoes, but we were not told so in
this MDA. (Morogoro Urban)
In many instances where mosquitoes were referred to, some community members thought
they only caused elephantiasis. Hydrocoele was seen to be due to a variety of other
causes:
There are mosquitoes of a particular species which bite people and cause elephantiasis.
We don’t know what causes hydrocoele. Perhaps men themselves can be good experts in
that because this happens in their environment. (Adult female, Lindi Urban)
Also, among drug distributors, the perceptions with regard to causes of lymphatic
ﬁlariasis chronic manifestations (hydrocoele and elephantiasis) varied. This was despite
the fact that one aspect in their training related to cause and transmission of lymphatic
ﬁlariasis, which they were in turn supposed to communicate to community members
during sensitization campaigns:
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As far as I know hydrocoele is that disease which a man can get as a result of ﬁlling up
with liquid. We call it ngiri maji. Elephantiasis is a disease which a person gets from
worms that are found in the water. The person gets the disease by entering into the water
and being bitten by insects living in the water with worms. (CDD, Lindi urban)
One CDD, however, had another idea about the aetiology of lymphatic ﬁlariasis:
I understand about this problem because I have been involved in drug distribution for
about 3 years. I attended the seminar and have learned that lymphatic ﬁlariasis is trans-
mitted by a mosquito called Culex and worms are the results of eating fruits that are not
washed properly and poor use of toilets. (Morogoro Urban)
The difference in understanding of the causes of lymphatic ﬁlariasis manifestations
among drug distributors reﬂects the lack of depth in the training provided to this
important group of stakeholders in the MDAs.
Community leaders, regardless of their areas of residence, also demonstrated that
understandings of lymphatic ﬁlariasis varied, especially with respect to its cause and
mode of transmission. This is also a reﬂection of weaknesses in communication strategies
among programme implementers. Community leaders are an important link in the com-
munication pathway between implementers at higher levels and recipient community
members. Any distortion at this level is bound to result in misunderstandings and lack
of appropriate knowledge.
Perceptions of MDA
Overall, community leaders and drug distributors perceived MDA activity posi-
tively. They generally expressed trust in the fact that MDA was beneﬁcial to individuals
and communities. The beneﬁts mentioned were related to lymphatic ﬁlariasis disease
prevention, cure or rehabilitation of several conditions. In one community, the village
leader gave an example to emphasize this point:
My child was suffering from skin itching but after using these drugs, the problem ended.
(Community leader, Morogoro Rural)
One of the community leaders put it succinctly when he said:
Yes there are beneﬁts; if a person is infected the drugs kill the infection and at the same
time build immunity. If taken for ﬁve years the disease is eradicated completely. The
mosquitoes that transmit the disease will no longer be able to do so; eventually there
will be no more infections. (Community leader, Lindi Rural)
Another community leader thought that the MDA was good because drugs were being
given to people free of charge:
Because they are provided freely, instead of using money to buy, it is good. (Morogoro
Rural)
Drug distributors gave almost the same account as community leaders with respect to
how they perceived the mass distribution of drugs. Their reservations, however, were
on the challenges they faced with the task of distributing drugs to community members.
The challenges mentioned include diverse reactions they encountered from the com-
munity members, some of whom believed they had no problems for which treatment
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was being provided, little or no trust from community members who thought CDDs
were not up to standard when handling medicine, as well as the difﬁculties of reaching
them given the terrain, distance, short time allocated and timing with the distribution.
The perceptions of CDDs of the MDA were summarized in these terms:
MDA has contributed to reducing problems associated with lymphatic ﬁlariasis. (Morogoro
Urban)
There were also appreciative reactions to MDA among community members, for instance
participants said:
I used to have ﬁlarial attacks but now I don’t have them. (Adult male, Lindi Rural)
and:
The drugs are both preventive and curative. For people not yet infected when they take
these drugs they don’t get the disease, for those with infections but no symptoms the para-
sites are killed. For those with early symptoms of the disease the symptoms disappear.
(Young female, Lindi Urban)
But there was also a lot of scepticism in relation to MDAs, and the aims of drug distri-
bution. A FGD participant explained:
Individuals beneﬁt by taking drugs because they are for prevention, except that the
circumstances under which the drugs are distributed are doubtful. There was a time when
a tailor died and people said it was because of these drugs. (Young female, Lindi Urban)
In Morogoro Rural, community members thought the drugs were provided to control
onchocerciasis because ivermectin had been used for several years to control onchocer-
ciasis before.
We heard about those drugs for onchocerciasis and albendazole. They were brought by
selected distributors. (Adult female, Morogoro Rural)
In some instances community members were reportedly protesting against treatment
for the disease, which was not their priority. One CDD recounted how he was rebuked
when he visited a house:
We don’t want your drugs. Instead of bringing us important things you come with drugs.
(Lindi Urban)
And yet still, some members of the community expressed their scepticism about the pro-
gramme. This was partly due to side-effects experienced or perceived by some community
members. For instance, one discussant had this to say:
Those who refused drugs had several reasons. Previously they took the drugs and they
became seriously ill so they associated the illness with the drugs. (Young female, Lindi
Urban)
Fears that drugs were really aimed at harming people, particular male sexual potency,
were not uncommon, as was observed by one CDD:
Problems were that some people were refusing to accept the drugs due to the belief that
drugs cause male impotence and when the father refuses, all people in that household
also refuse. (Morogoro Urban)
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These misconceptions were also observed with respect to lymphatic ﬁlariasis being a
disease for rural areas rather than the population in urban areas.
Many people have the problems but when we tell them about drugs they refuse saying
this disease is for rural areas and not urban areas. (CDD, Morogoro Urban)
An older woman, representing community feelings of conspiracy, said:
We don’t trust free drugs; they have been brought to ﬁnish us off. People believe that
these drugs have a hidden agenda that is the main reason; other reasons are just excuses.
Free drugs are brought to kill us. People are afraid to use even the free bed nets provided.
They don’t use them to protect themselves or their children against mosquitoes but rather
they use them to store their harvest. (Lindi Rural)
Experiences with, or rumours about adverse effects of drugs were cited by CDDs and
community members as being among the reasons for low drug uptake. A range of effects
were reported by those who had been affected and/or whose relatives, or people they
knew, had been affected by taking drugs. The perceived effects included fever, dizziness,
vomiting, nausea, severe itching and swelling of different parts of the bodies. The lack
of explanation for the adverse effects most likely fuelled the existing rumour about
drugs and the aim of distribution.
Those who refused drugs had several reasons. They said drugs kill. Previously they took
the drugs and they got seriously ill so they associated their experiences with the drugs.
Some of them claimed the drugs were for experimentation. Others say that we are given
the drugs so that we don’t reproduce. (Young female, Lindi Urban)
In some communities, the distribution process was said to have contributed to the MDA
being perceived negatively. The involvement of community members in the distribution
of drugs was not a new phenomenon in the study districts. However, it was observed
that some community members were not pleased with this practice as they felt they could
not trust people whom they knew to have never received even basic training in handling
drugs. As one discussant put it:
Nurses and health workers should be used to do the distribution, not these community
members who have caused many to refuse taking the drugs. (Young female, Lindi Urban)
Some of community members were of the opinion that the practice of measuring
heights of individuals instead of their weight as the basis for determining dosage for
ivermectin was one of the reasons for their doubts and refusal to take drugs. One female
participant voiced this concern when she said:
This practice should be changed. It is better to measure weight for dosage because using
height a child may take more tablets than the father and therefore cause misunderstanding.
(Young female, Lindi urban)
Discussion
The present study formed part of a larger project that aimed to identify barriers and
strategies for improving drug coverage in rural and urban areas under the MDA pro-
gramme for lymphatic ﬁlariasis control in Tanzania. A quantitative household survey
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carried out in parallel with the present study established that the overall drug uptake
rate at the study sites in 2011 was only 55.1% (Kisoka et al., 2014). According to
WHO, coverage is required to be a minimum of 65% of the population to break trans-
mission over a period of 5–6 years (WHO, 2011). However, mathematical modelling
has shown that a higher coverage and/or longer treatment periods may be required in
areas with very high pre-control lymphatic ﬁlariasis prevalence rates (Michael et al.,
2004). Efforts to increase coverage need to examine pertinent dimensions of the relation-
ship between the intervention and the targeted communities. Therefore in this study, the
focus was on the populations’ perceptions of, and experiences with, MDA in the context
of the health concerns and health care challenges that communities face.
A recent literature review by Krentel et al. (2013), focusing on factors that affect
individual compliance with MDA for lymphatic ﬁlariasis, mentioned ﬁve key in-
gredients in promoting success: attention to trust issues, adaptation to local conditions,
minimization of adverse effects of the drugs, promotion of the broader beneﬁts of the
MDA programme and addressing the challenge of systematic non-compliance. Parker &
Allen (2013) aimed to turn attention towards the international players’ responsibility for
changing this scenario rather than continuing to focus on the ‘hearts and minds’ of the
communities targeted for treatment. Among such international players are pharmaceutical
companies, which play a role, for better or worse, in MDA interventions (Samsky, 2011,
2012).
The CDI strategy has, in the last decade, increasingly been applied with a view to
addressing challenges to access to, and coverage of, MDA-based interventions through
promoting community mobilization, participation and ownership. It was developed
and applied in 1995 to strengthen community involvement and ownership and ensure
that rural and remote villages received annual doses of ivermectin to control onchocer-
ciasis. Community-directed intervention has since been applied to increase access to
malaria treatment, Vitamin A and deworming medicine (CDI Study Group, 2010).
The CDI strategy has much potential but MDA through the CDI strategy faces a number
of challenges. A central component of MDA implemented through the CDI strategy is
the emphasis on advocacy and mobilization among local stakeholders and, furthermore,
the emphasis on information and communication about the campaign and its aims
and means (CDI Study Group, 2010). This process should ideally allow for a genuine
dialogue, including in-depth information sharing and discussions on various aspects
of the intervention (Amazigo et al., 2012). The programme staff and implementers’
approach to information, education and communication about lymphatic ﬁlariasis and
MDA should take centre stage in the implementation process, preferable supported by
primary and secondary school curriculum and adult education programmes. This is both
a costly and hugely complex task, but necessary for a more successful intervention.
A good level of understanding of the disease’s aetiology, development of the infec-
tion and its manifestations is important for peoples’ acceptance of MDA, not just to
dispel misconceptions and promote shared understandings of lymphatic ﬁlariasis and
the distributed drugs. It is just as much a means of promoting ownership and digniﬁed
informed participation in the intervention. The population should feel that their views
and concerns matter. Through communication, debate and education, positive citizen-
ship and a sense of ownership and belonging is promoted. Unfortunately, the FGDs
showed that people did not feel they were adequately informed during the campaign.
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In addition, the study indicated that there was considerable variation in how com-
munity members both within and across study districts perceived the MDA and dis-
tributed drugs; some community members appreciated the distribution of drugs, and
requested the drugs from local health facilities if they missed the distribution. Others
wished to avoid the drugs due to lack of conﬁdence in the rationale for drug distribution
or fears of adverse effects of the drugs. The relationship between the vector, the parasite
and eventual disease manifestations is complicated and not easy to explain and under-
stand and the study shows that there was considerable uncertainty and misunder-
standings about this among community members. In this respect, the programme could
consider identifying a proper Swahili term for lymphatic ﬁlariasis which should be
descriptive enough to promote a better understanding of the fact that the serious disease
complications of elephantiasis and hydrocele are both consequences of the lymphatic
ﬁlariasis infection. Moreover, regular training targeting CDDs should be provided to
enable them to inform and discuss with community members and address their request
for adequate information, and NTD staff at national, regional and district levels should
be refreshed on the principles and values of CDI and primary health care.
The review by Krentel et al. (2013) listed studies that reported good compliance
with MDA of people who perceived themselves to be at risk of lymphatic ﬁlariasis
infection, while another study observed that lack of tangible results of taking drugs
raises suspicion about the actual aim of the programme (Parker & Allen, 2012). Most
community members were familiar with the conditions of elephantiasis and hydrocoele
because they were familiar with people who suffered from these conditions. In other
communities, lymphatic ﬁlariasis was mentioned among health problems being faced
by people, apparently because the research team had informed them of the purpose of
the study. However, most community members were unfamiliar with the cause and
mode of transmission of lymphatic ﬁlariasis; and the fact that elephantiasis and hydro-
coele are manifestations of the same infection. This led community members to suggest
that drugs should only be given to those with hydrocoele and elephantiasis or, alter-
natively, people should be screened to determine if they had infections so as to avoid
dispensing drugs to people without evidence of infection. As one CDD explained:
We did not encounter many problems except that some people refused to take the drugs,
saying that they would not take it, because they were not sick.
Manderson wrote that neglected tropical diseases exist for social and economic reasons
and that persistent poverty and inequality contribute to their continued existence
(Manderson et al., 2009). At the same time, impoverished population groups may not
necessarily prioritize treatment for lymphatic ﬁlariasis as they are already facing a
number of life-threatening conditions such as malaria and respiratory diseases, for
which the required health care and interventions are inadequate at best or even non-
existent (Bhullar & Maikere, 2010; Parker & Allen, 2012; Samuelsen et al., 2013). Re-
search participants expressed disappointment in the political leaders and their inability
to stand up for their communities and promote positive change, leaving people feeling
deserted and socially and politically marginalized. The failure to address such chal-
lenges as poor health care, the severe lack of essential medicines and social and political
marginalization, which impact on the daily lives of poor communities, angered some
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focus group participants and, as noted above, led one community member to exclaim to
a distributor:
We don’t want your drugs. Instead of bringing us important things you come with drugs.
In spite of this dire opposition, there is huge and promising potential in the positive
spirit with which some community members and drug distributors took part in MDA
and received the drugs. One community leader made this point clearly when he said,
This is a gradual process which needs time to reach its target. (Morogoro Urban)
The study documented positive viewpoints and a feeling of empowerment among some
community members towards both the short-term effects of the drugs and also occa-
sional positive and optimistic sentiments and understandings of the long-term potential
of MDA to eliminate lymphatic ﬁlariasis.
It should also be noted that although many community members after drug dis-
tribution appeared to be discontented with the programme, it is not known to what
extent this dissatisfaction resulted in an individual decision to not accept the treatment.
A quantitative household survey in the same communities (Kisoka et al., 2014) found
that the overall drug uptake rate in 2011 was only 55.1%, but according to this study
component, the main reason for this was not that people refused the drugs, but that
they were never offered it during the campaign for various reasons. The study therefore
concluded that improved drug uptake relied more on programme-related factors that
are modiﬁable, than on perceptions and practices of the target population. This present
study has identiﬁed other programme-related challenges that can and should be addressed
by programme stakeholders. More importantly, as other social scientist have pointed out
(Parker et al., 2008; Manderson, 2012), international, national and local institutions and
power holders must pay attention to the needs and priorities of ‘neglected populations’
if MDA is to live up to its promises over time.
Conclusions
While global and national health policy push for MDA for control of lymphatic
ﬁlariasis as necessary to interrupt lymphatic ﬁlariasis transmission, community members
and representatives who were given a voice in this study said that they had other, more
pressing, concerns and they felt excluded from information and communication about
the campaign. The programme, to a great extent, was unable to fully engage the recipient
communities in the important stages of the process. While the NTD programme allegedly
followed the community-directed approach to implementing MDAs, central elements of
this policy seemed to be missing from the point of view of community members. To
address the observed shortcomings, it is important that national-, regional- and district-
level authorities take the community-directed approach seriously and involve communi-
ties from the early stages of MDA planning and implementation. Community mobiliza-
tion and ownership form the backbone of community-directed distribution and these
cannot develop if information and dialogue is not prioritized as an essential part of the
process. The concerns and challenges of the neglected populations need to be taken into
consideration to sustain and improve acceptability and support for the MDA-based
control activities.
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